Display options
Cite
Magnetic Resonance Imaging as an Adjunct to Mammography for Breast Cancer Screening in Women at Less Than High Risk for Breast Cancer: A Health Technology Assessment. Ont Health Technol Assess Ser. 2016;16(20):1-30
(2016). Magnetic Resonance Imaging as an Adjunct to Mammography for Breast Cancer Screening in Women at Less Than High Risk for Breast Cancer: A Health Technology Assessment. Ontario health technology assessment series, 16(20), 1-30.
"Magnetic Resonance Imaging as an Adjunct to Mammography for Breast Cancer Screening in Women at Less Than High Risk for Breast Cancer: A Health Technology Assessment." Ontario health technology assessment series vol. 16,20 (2016): 1-30.
Magnetic Resonance Imaging as an Adjunct to Mammography for Breast Cancer Screening in Women at Less Than High Risk for Breast Cancer: A Health Technology Assessment. Ont Health Technol Assess Ser. 2016 Nov 01;16(20):1-30. eCollection 2016. PMID: 27990198; PMCID: PMC5156844.
Copy Download .nbib Format: NLM
Share it on

Ont Health Technol Assess Ser. 2016 Nov 01;16(20):1-30. eCollection 2016.

Magnetic Resonance Imaging as an Adjunct to Mammography for Breast Cancer Screening in Women at Less Than High Risk for Breast Cancer: A Health Technology Assessment.

Ontario health technology assessment series

[No authors listed]

PMID: 27990198 PMCID: PMC5156844

Abstract

BACKGROUND: Screening with mammography can detect breast cancer early, before clinical symptoms appear. Some cancers, however, are not captured with mammography screening alone. Among women at high risk for breast cancer, magnetic resonance imaging (MRI) has been suggested as a safe adjunct (supplemental) screening tool that can detect breast cancers missed on screening mammography, potentially reducing the number of deaths associated with the disease. However, the use of adjunct screening tests may also increase the number of false-positive test results, which may lead to unnecessary follow-up testing, as well as patient stress and anxiety. We investigated the benefits and harms of MRI as an adjunct to mammography compared with mammography alone for screening women at less than high risk (average or higher than average risk) for breast cancer.

METHODS: We searched Ovid MEDLINE, Ovid Embase, Cochrane Central Register of Controlled Trials, Cochrane Database of Systematic Reviews, Database of Abstracts of Reviews of Effects (DARE), Centre for Reviews and Dissemination (CRD) Health Technology Assessment Database, and National Health Service (NHS) Economic Evaluation Database, from January 2002 to January 2016, for evidence of effectiveness, harms, and diagnostic accuracy. Only studies evaluating the use of screening breast MRI as an adjunct to mammography in the specified populations were included.

RESULTS: No studies in women at less than high risk for breast cancer met our inclusion criteria.

CONCLUSIONS: It remains uncertain if the use of adjunct screening breast MRI in women at less than high risk (average or higher than average risk) for breast cancer will reduce breast cancer-related mortality without significant increases in unnecessary follow-up testing and treatment.

References

  1. Radiology. 2011 Nov;261(2):421-7 - PubMed
  2. Ann Intern Med. 2008 May 6;148(9):671-9 - PubMed
  3. JAMA Oncol. 2015 Oct;1(7):888-96 - PubMed
  4. Lancet Oncol. 2005 Oct;6(10 ):798-808 - PubMed
  5. Ann Surg Oncol. 2007 Mar;14(3):1051-7 - PubMed
  6. N Engl J Med. 1985 Jan 17;312(3):146-51 - PubMed
  7. AJR Am J Roentgenol. 2015 Feb;204(2):234-40 - PubMed
  8. Eur J Cancer. 2001 Mar;37(4):463-9 - PubMed
  9. Cochrane Database Syst Rev. 2013 Jun 04;(6):CD001877 - PubMed
  10. Breast Cancer Res Treat. 2006 May;97(2):135-44 - PubMed
  11. J Surg Res. 2015 Feb;193(2):519-22 - PubMed
  12. Ont Health Technol Assess Ser. 2010;10(3):1-55 - PubMed
  13. Cancer. 2006 May 15;106(10):2104-12 - PubMed
  14. Ann Intern Med. 2015 May 19;162(10 ):673-81 - PubMed
  15. J Natl Cancer Inst. 1989 Dec 20;81(24):1879-86 - PubMed
  16. Ann Intern Med. 2009 Nov 17;151(10):716-26, W-236 - PubMed
  17. Breast Cancer Res Treat. 2006 Nov;100(1):109-19 - PubMed
  18. Lancet. 2005 May 21-27;365(9473):1769-78 - PubMed
  19. J Natl Compr Canc Netw. 2009 Nov;7(10 ):1060-96 - PubMed
  20. Cancer Prev Control. 1998 Oct;2(5):213-20 - PubMed
  21. Radiology. 2011 Nov;261(2):414-20 - PubMed
  22. Hum Pathol. 1991 Dec;22(12):1232-9 - PubMed
  23. Br J Cancer. 2004 Oct 18;91(8):1580-90 - PubMed
  24. J Clin Oncol. 2007 Apr 10;25(11):1329-33 - PubMed
  25. CMAJ. 2011 Nov 22;183(17):1991-2001 - PubMed
  26. J Clin Oncol. 2010 Dec 20;28(36):5265-73 - PubMed
  27. Ann Intern Med. 2016 Feb 16;164(4):279-96 - PubMed
  28. J Clin Oncol. 2014 Aug 1;32(22):2304-10 - PubMed
  29. N Engl J Med. 2015 Jun 11;372(24):2353-8 - PubMed
  30. Ann Intern Med. 2016 Feb 16;164(4):268-78 - PubMed
  31. Br J Cancer. 2004 Jun 1;90(11):2118-22 - PubMed
  32. J Clin Oncol. 2002 Jun 1;20(11):2701-12 - PubMed
  33. J Am Coll Radiol. 2013 Jan;10(1):11-4 - PubMed
  34. J Natl Cancer Inst. 1998 Aug 5;90(15):1138-45 - PubMed
  35. JAMA. 2012 Apr 4;307(13):1394-404 - PubMed
  36. Ann Intern Med. 2003 Feb 4;138(3):168-75 - PubMed
  37. Stat Med. 2004 Apr 15;23(7):1111-30 - PubMed
  38. Ont Health Technol Assess Ser. 2007;7(1):1-32 - PubMed
  39. Ont Health Technol Assess Ser. 2016 Jul 01;16(15):1-71 - PubMed
  40. Cancer Epidemiol Biomarkers Prev. 2013 Jan;22(1):146-9 - PubMed
  41. Breast Cancer Res Treat. 2014 Jun;145(3):765-73 - PubMed
  42. Radiology. 2015 Nov;277(2):527-37 - PubMed
  43. CA Cancer J Clin. 2007 Mar-Apr;57(2):75-89 - PubMed
  44. Breast Cancer Res Treat. 2013 Nov;142(2):445-53 - PubMed
  45. JAMA. 1996 Jul 3;276(1):33-8 - PubMed
  46. PLoS Med. 2009 Jul 21;6(7):e1000097 - PubMed

MeSH terms

Publication Types